Evolving research in nongenomic actions of aldosterone

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 20, Issue 3, 2013, Pages 198-203

  Williams, Jonathan S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Aldosterone; Mineralocorticoid receptor; Nongenomic

Indexed keywords

ALDOSTERONE; CALMODULIN; CAVEOLIN 1; EPIDERMAL GROWTH FACTOR RECEPTOR; EPITHELIAL SODIUM CHANNEL; G PROTEIN COUPLED RECEPTOR; MINERALOCORTICOID RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN KINASE C; SERUM AND GLUCOCORTICOID REGULATED KINASE 1;

BINDING SITE; CELL MEMBRANE; HORMONE RECEPTOR INTERACTION; HUMAN; MOLECULAR INTERACTION; ONCOGENE SRC; PALMITOYLATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN POLYMORPHISM; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

ALDOSTERONE; ANIMALS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; CELL MEMBRANE; HUMANS; METABOLIC SYNDROME X; RECEPTORS, MINERALOCORTICOID; SECOND MESSENGER SYSTEMS;

EID: 84879198397     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0b013e328360c200     Document Type: Review

References (51)

1. Mortensen RM, Williams GH. Aldosterone action. In: DeGroot LJ, editor. Endocrinology, 3rd ed. Philadelphia: WB Saunders Co; 1995. pp. 1668- 1676.
2. Tait SA, Tait JF, Coghlan JP. The discovery, isolation and identification of aldosterone: reflections on emerging regulation and function. Mol Cell Endocrinol 2004; 217:1-21. (Pubitemid 38596623)
3. Dluyh RG, Axelrod L, Underwood RH, et al. Studies of the control of plasma aldosterone concentration in normal man: II. Effect of dietary potassium and acute potassium infusion. J Clin Invest 1972; 51:1950-1957.
4. Funder JW. Aldosterone and mineralocorticoid receptors: a personal reflection. Mol Cell Endocrin 2012; 350:146-150.
5. Williams JS, Williams GH. 50th anniversary of aldosterone. J Clin Endocrin Metab 2004; 88:2364-2372. (Pubitemid 36724399)
6. Stowasser M, Sharman J, Leano R, et al. Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type 1. J Clin Endocrinol Metab 2005; 90:5070-5076. (Pubitemid 41262256)
7. Gomez-Sanchez EP, Ahmad N, Romero DG, et al. Origin of aldosterone in the rat heart. Endocrinology 2004; 145:4796-4802. (Pubitemid 39551092)
8. Luther JM, Brown NJ. The renin-angiotensin-aldosterone system and glucose homeostasis. Trends Phamacol Sci 2011; 32:734-739.
9. Briet M, Schiffrin EL. Vascular actions of aldosterone. J Vasc Res 2013; 50:88-89.
10. Calvier L, Miana M, Reboul P, et al. Galectin-3 mediates aldosterone-induced vascular fibrosis. Arterioscler Thromn Vasc Biol 2013; 33:67-75.
11. Bienvenu LA, Morgan J, Rickard AJ, et al. Macrophage mineralocorticoid receptor signaling plays a key role in aldosterone-independent cardiac fibrosis. Endocrinology 2012; 153:3416-3425.
12. Selye H. The general adaptation syndrome and the diseases of adaptation. J Clin Endocrinol 1946; 6:117-230.
13. Brilla CG, Pick R, Tan LP, et al. Remodeling of the rat right and left ventricle in experimental hypertension. Circ Res 1990; 67:1355-1364.
14. Pitt B, Zannad F, Remme WJ. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999; 341:709- 717. (Pubitemid 29407370)
15. Asher C, Wald H, Rossier BC, et al. Aldosterone-induced increase in the abundance of Na+ channel subunits. Am J Physiol 1996; 271:C605-C611.
16. Pearce D. SGK-1 regulation of epithelial sodium transport. Cell Physiol Biochem 2003; 13:13-20. (Pubitemid 36359377)
17. Fodstad H, Gonzalez-Rodriguez E, Bron S, et al. Effects of mineralocorticoid and K+ concentration on K+ secretion and ROMK channel expression in a mouse cortical collecting duct cell line. Am J Physiol Renal Physiol 2009; 296:F966-F975.
18. Dooley R, Harvey BJ, Thomas W. Nongenomic actions of aldosterone: from receptors and signals to membrane targets. Mol Cell Endocrin 2012; 350:223-234.
19. Hendron E, Stockand JD. Activation of mitogen-activated protein kinase (mitogen-activated protein kinase/extracellular signal-regulated kinase) cascade by aldosterone. Mol Biol Cell 2002; 13:3042-3054. (Pubitemid 35034244)
20. Markos F, Healy V, Harvey BJ. Aldosterone rapidly activates Na+/H+ exchange in M-1 cortical collecting duct cells via a PKC-MAPK pathway. Nephron Physiol 2005; 99:1-9.
21. Krug AW, Grossmann C, Schuster C, et al. Aldosterone stimulates epidermal growth factor receptor expression. J Biol Chem 2003; 278:43060-43066. (Pubitemid 37345921)
22. Callera GE, Yogi A, Briones AM, et al. Vascular proinflammatory responses by aldosterone are mediated via a c-Src trafficking to cholesterol-rich microdomains: role of PDGFR. Cardiovasc Res 2011; 91:720-731.
23. Grossmann C, Krug AW, Freudinger R, et al. Aldosterone-induced EGFR expression: interaction between the human mineralocorticoid receptor and the human EGFR promoter. Am J Physiol Endocrinol Metab 2007; 292: E1790-E1800. (Pubitemid 47084715)
24. Gros R, Ding Q, Liu B, et al. Aldosterone mediates its rapid effects in vascular endothelial cells through GPER/GPR30 activation. Am J Physiol Cell Physiol 2013 [Epub ahead of print]. doi:10.1152/ajpcell.00203.2012.
25. Gros R, Ding Q, Sklar L, et al. GPR30 Expression is required for the mineralocorticoid receptor-independent rapid vascular effects of aldosterone. Hypertension 2011; 57:442-451.
26. Krug AW, Pojoga LH, Williams GH, et al. Cell membrane-associated mineralocorticoid receptors? New evidence. Hypertension 2011; 57:1019-1025.
27. Pojoga LH, Coutinho P, Rivera A, et al. Activation of the mineralocorticoid receptor increases striatin levels. Am J Hypertens 2012; 25:243-249.
28. Gros R, Ding Q, Davis M, et al. Delineating the receptor mechanisms underlying the rapid vascular contractile effects of aldosterone and estradiol. Can J Physiol Pharmacol 2011; 89:655-663.
29. Kim HP, Lee JY, Jeong JK, et al. Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor alpha localized in caveolae. Biochem Biophys Res Commun 1999; 263:257-262.
30. Razandi M, Pedram A, Levin ER. Heat shock protein 27 is required for sex steroid receptor trafficking to and function at the plasma membrane. Mol Cell Biol 2010; 30:3249-3261.
31. Matthews L, Berry A, Ohanian V, et al. Caveolin mediates rapid glucocorticoid action to the antiproliferative program. Mol Endocrinol 2008; 22:1320-1330. (Pubitemid 351786993)
32. Revankar CM, Cimino DF, Sklar LA, et al. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005; 307:1625- 1630. (Pubitemid 40354745)
33. Marino M, Ascenzi P. Steroid hormone rapid signaling: the pivotal role of S-palmitoylation. IUBMB Life 2006; 58:716-719. (Pubitemid 46900132)
34. Grossmann C, Husse B, Mildenberger S, et al. Colocalization of mineralocorticoid and EFG receptor at the plasma membrane. Biochim Biophys Acta 2010; 1803:584-590.
35. Krug AW, Schuster C, Gassner B, et al. Human epidermal growth factor receptor-1 expression renders Chinese hamster ovary cells sensitive to alternative aldosterone signaling. J Biol Chem 2002; 277:45892-45897. (Pubitemid 35417570)
36. Moe OW. Acute regulation of proximal tubule apical membrane Na/H exchanger NHE-3: role of phosphorylation, protein trafficking, and regulatory factors. J Am Soc Nephrol 1999; 10:2412-2425. (Pubitemid 29501477)
37. Nielsen J, Kwon TH, Frøkiaer J, et al. Maintained ENaC trafficking in aldosterone- infused rats during mineralocorticoid and glucocorticoid receptor blockade. Am J Physiol Renal Physiol 2007; 292:F382-F394. (Pubitemid 46105276)
38. Castets F, Bartoli M, Barnier JV, et al. A novel calmodulin-binding protein, belonging to the WD-repeat family, is localized in dendrites of a subset of CNS neurons. J Cell Biol 1996; 134:1051-1062. (Pubitemid 26278227)
39. Lu Q, Pallas DC, Surks HK, et al. Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor alpha. Proc Natl Acad Sci USA 2004; 101: 17126-17131. (Pubitemid 39627785)
40. Ricchiuti V, Lapointe N, Pojoga L, et al. Dietary sodium intake regulates angiotensin II type 1, mineralocorticoid receptor, and associated signaling protein in heart. J Endocrinol 2011; 211:47-54.
41. Pojoga LH, Adamova Z, Kumar A, et al. Sensitivity of NOS-dependent vascular relaxation pathway to mineralocorticoid receptor blockade in caveolin- 1 deficient mice. Am J Physiol Heart Circ Physiol 2010; 298:H1776- H1788.
42. Pojoga LH, Romero JR, Yao TM, et al. Caveolin-1 ablation reduces the adverse cardiovascular effects of N-omega-nitro-l-arginine methyl ester and angiotensin II. Endocrinology 2010; 151:1236-1246.
43. Pojoga LH, Yao TM, Sinha S, et al. Effect of dietary sodium on vasoconstriction and eNOS-mediated vascular relaxation in caveolin-1-deficient mice. Am J Physiol Heart Circ Physiol 2008; 294:H1258-H1265. (Pubitemid 351468722)
44. Bunda S, Wang Y, Mitts TF, et al. Aldosterone stimulates elastogenesis in cardiac fibroblasts via mineralocorticoid receptor-independent action involving the consecutive activation of Galpha13, c-Src, the insulin-like growth factor-I receptor, and phosphatidylinositol 3-kinase/Akt. J Biol Chem 2009; 284:16633-16647.
45. Grossmann C, Benesic A, Krug AW, et al. Human mineralocorticoid receptor expression renders cells responsive for nongenotropic aldosterone actions. Mol Endocrinol 2005; 19:1697-1710. (Pubitemid 41007884)
46. Carmeci C, Thompson DA, Ring HZ, et al. Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer. Genomics 1992; 45:607- 617. (Pubitemid 27506136)
47. Filardo EJ. Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer. J Steroid Biochem Mol Biol 2002; 80:231-238. (Pubitemid 34233742)
48. Haas E, Bhattacharya I, Brailoiu E, et al. Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. Circ Res 2009; 104:288-291.
49. Lindsey SH, Cohen JA, Brosnihan KB, et al. Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2 Lewis rats. Endocrinology 2009; 150:3753-3758.
50. Meyer MR, Baretella O, Prossnitz ER, et al. Dilation of epicardial coronary arteries by the G protein-coupled estrogen receptor agonists G-1 and ICI 182 780. Pharmacology 2010; 86:58-64.
51. Yu X, Ma H, Barman SA, et al. Activation of G protein-coupled estrogen receptor (GPER) induces endothelium independent relaxation of coronary artery smooth muscle. Am J Physiol Endocrinol Metab 2011; 301:E882- E888.